| dc.creator |
Dincel, C |
|
| dc.creator |
Kosar, A |
|
| dc.creator |
Arikan, N |
|
| dc.date |
1999-04-01T00:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:29:18Z |
|
| dc.date.available |
2021-12-03T11:29:18Z |
|
| dc.identifier |
5cef70af-9929-4731-953b-39532e018f2b |
|
| dc.identifier |
10.1080/003655999750016096 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/5cef70af-9929-4731-953b-39532e018f2b/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/92096 |
|
| dc.description |
Objective: To find the efficacy and optimal dosage of oxybutynin HCl in a group of enuretic children, who were non-responsive to imipramine. Material and Methods: Thirty-six patients with enuresis who were non-responsive to imipramine were urodynamically assessed and subsequently treated with oxybutynin hydrochloride (HCl). Patients with inadequate bladder storage function (IBSF) were started on 10-mg daily oxybutynin HCl for one month. If the initial treatment was found to be inadequate, the dose was increased to 15 mg daily. The dose in patients who were non-responsive to 15-mg daily dose was increased to 20-mg daily dose. Patients who were normal urodynamically were treated with a dose of 15 mg daily for one month. Results: Before the treatment, 17 patients had IBSF (47.2%). The majority of the patients (88.2%) with IBSF were responsive to the 15-mg daily oxybutynin HCl. The treatment in patients with normal bladder function was generally unsuccessful. Conclusions: Oxybutynin HCl in sufficient dosages seems to be effective in the treatment of enuretic patients with IBSF. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Effectiveness of oxybutynin hydrochloride in the treatment of enuresis nocturna - A clinical and urodynamic study |
|
| dc.type |
info:eu-repo/semantics/article |
|